We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of DCPH yet.

DCPH Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2024, worth a combined $0 — down 100% from $759K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DCPH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $759K sold.

  • 0 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2024, down from 1 in Q2 2024.
  • Funds reported $0 of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of -1 holder.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2024 was DekaBank Deutsche Girozentrale, an estimated $759K sold.

Based on aggregated 13F filings for Q3 2024.